Home/Filings/4/0001764046-21-000037
4//SEC Filing

Ahmed Mukhtar 4

Accession 0001764046-21-000037

CIK 0001764046other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:30 PM ET

Size

22.7 KB

Accession

0001764046-21-000037

Insider Transaction Report

Form 4
Period: 2021-03-11
Ahmed Mukhtar
President, Science Group
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-03-11$6.91/sh+138,743$958,714189,453 total
  • Exercise/Conversion

    Ordinary Shares

    2021-03-11$10.85/sh+20,947$227,275210,400 total
  • Tax Payment

    Ordinary Shares

    2021-03-11$22.76/sh9,534$216,994200,866 total
  • Tax Payment

    Ordinary Shares

    2021-03-11$23.00/sh1,622$37,306199,244 total
  • Tax Payment

    Ordinary Shares

    2021-03-11$22.77/sh40,918$931,703158,326 total
  • Sale

    Ordinary Shares

    2021-03-11$22.88/sh107,616$2,462,25450,710 total
  • Exercise/Conversion

    Ordinary Shares

    2021-03-12$10.85/sh+78,155$847,982128,865 total
  • Tax Payment

    Ordinary Shares

    2021-03-12$23.18/sh36,582$847,97192,283 total
  • Sale

    Ordinary Shares

    2021-03-12$23.28/sh41,573$967,81950,710 total
  • Exercise/Conversion

    Stock Options

    2021-03-11138,7430 total
    Exercise: $6.91Exp: 2028-03-08Ordinary Shares (138,743 underlying)
  • Exercise/Conversion

    Stock Options

    2021-03-1120,94778,155 total
    Exercise: $10.85Exp: 2028-03-08Ordinary Shares (20,947 underlying)
  • Exercise/Conversion

    Stock Options

    2021-03-1278,1550 total
    Exercise: $10.85Exp: 2028-03-08Ordinary Shares (78,155 underlying)
Footnotes (4)
  • [F1]Represents shares withheld for payment of exercise price.
  • [F2]The price is a weighted average price. The prices actually received ranged from $22.52 to $23.22. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The price is a weighted average price. The prices actually received ranged from $23.045 to $23.66. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
  • [F4]Represents the remaining portion of a March 8, 2018 grant of stock options. The reported stock options became exercisable on November 30, 2020.

Issuer

CLARIVATE Plc

CIK 0001764046

Entity typeother

Related Parties

1
  • filerCIK 0001802889

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:30 PM ET
Size
22.7 KB